<p>Clover Health Investments, Corp.（納斯達克代碼：CLOV - 獲取免費報告）的股票獲得了六位分析師的共識推薦，評級為 “適度買入”，Marketbeat 報道稱。其中一位分析師給予該股票賣出評級，兩位分析師給予持有評級，兩位分析師給予買入評級，還有一位分析師給予強烈買入評級。在過去一年中，更新了對該股票覆蓋的經紀人中，12 個月的平均目標價為 3.9250 美元。</p>
<ul>
<li>MarketBeat 週迴顧 – 03/03 - 03/07</li>
</ul>
<p>幾位股票分析師對該公司進行了評論。Zacks Research 在 10 月 24 日（星期五）的研究報告中將 Clover Health Investments 的評級從 “持有” 上調至 “強烈買入”。Weiss Ratings 在週三的研究報告中重新發布了對 Clover Health Investments 股票的 “賣出（d-）” 評級。Canaccord Genuity Group 在 11 月 6 日（星期四）的研究報告中將 Clover Health Investments 的目標價從 4.10 美元下調至 3.70 美元，並對該股票給予 “買入” 評級。Wall Street Zen 在 11 月 15 日（星期六）的報告中將 Clover Health Investments 的評級從 “持有” 下調至 “賣出”。最後，Leerink Partners 在 10 月 21 日（星期二）的研究報告中對 Clover Health Investments 的股票設定了 3.00 美元的目標價，並給予該股票 “市場表現” 評級。</p>
<p><strong>閲讀我們關於 CLOV 的最新報告</strong></p>
<h2>機構投資者對 Clover Health Investments 的看法</h2>
<ul>
<li>錯過了 Hims &amp; Hers 的上漲？Clover Health 可能是下一個</li>
</ul>
<p>一些機構投資者和對沖基金最近買入和賣出了 CLOV 的股票。Vanguard Group Inc. 在第一季度將其在 Clover Health Investments 的持股增加了 5.1%。Vanguard Group Inc. 現在擁有 20580117 股該公司的股票，價值 73883000 美元，此前在上個季度又購買了 994904 股。Geode Capital Management LLC 在第二季度將其在 Clover Health Investments 的持股增加了 95.7%。Geode Capital Management LLC 現在擁有 9843349 股該公司的股票，價值 27467000 美元，此前在上個季度又收購了 4812368 股。Millennium Management LLC 在第一季度將其在 Clover Health Investments 的持股增加了 365.9%。Millennium Management LLC 現在擁有 5804006 股該公司的股票，價值 20836000 美元，此前在此期間又購買了 4558305 股。美國銀行（Bank of America Corp DE）在第二季度將其在 Clover Health Investments 的持股增加了 217.5%。美國銀行（Bank of America Corp DE）現在擁有 4012744 股該公司的股票，價值 11196000 美元，此前在此期間又購買了 2748783 股。最後，Divisadero Street Capital Management LP 在第三季度購買了價值約 8470000 美元的 Clover Health Investments 新股份。19.77% 的股票由機構投資者持有。</p>
<h2>Clover Health Investments 股票上漲 5.6%</h2>
<p>Clover Health Investments 股票在週五開盤價為 2.28 美元。Clover Health Investments 的 12 個月最低價為 2.12 美元，最高價為 4.87 美元。該公司的 50 日移動平均價格為 2.92 美元，200 日移動平均價格為 2.94 美元。該公司的市值為 11.8 億美元，市盈率為-20.73，貝塔係數為 2.07。</p>
<p>Clover Health Investments（納斯達克代碼：CLOV - 獲取免費報告）最近於 11 月 4 日（星期二）發佈了季度財報。該公司報告的每股收益為（0.05 美元），低於分析師的共識預期（0.02 美元）0.07 美元。Clover Health Investments 的股本回報率為-16.79%，淨利潤率為-3.29%。該公司在本季度的收入為 4.9665 億美元，而分析師的預期為 4.6718 億美元。作為一個整體，賣方分析師預測 Clover Health Investments 在當前財政年度的每股收益將為-0.12 美元。</p>
<h2>關於 Clover Health Investments</h2>
<p>（獲取免費報告）</p>
<p>Clover Health Investments, Corp. 在美國提供醫療保險優勢計劃。它通過兩個部門運營：保險和非保險。它還提供 Clover Assistant，這是一個基於雲的軟件平台，使醫生能夠更早地檢測、識別和管理慢性疾病；併為他們治療的患者提供數據驅動和個性化的見解。</p>
<h2>精選故事</h2>
<ul>
<li>五隻我們更看好的股票，勝過 Clover Health Investments</li>
<li>ETF 篩選器：用途和逐步指南</li>
<li>Rocket Lab 剛經歷了第一次真正的崩潰——反彈可能更大</li>
<li>市盈率計算：如何評估股票</li>
<li>MarketBeat 週迴顧 – 11/17 - 11/21</li>
<li>消費者物價指數測量什麼？</li>
<li>一個宏偉的人工智能投資？Stanley Druckenmiller 最新的科技動態</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg"/></p>
<p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1000 美元在 Clover Health Investments 嗎？</h2>
<p>在你考慮 Clover Health Investments 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前立即購買……而 Clover Health Investments 並不在名單上。</p>
<p>雖然 Clover Health Investments 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

三葉草健康

<p>Clover Health Investments, Corp.（納斯達克代碼：CLOV）獲得了六位分析師的共識 “適度買入” 推薦。該股票的 12 個月平均目標價為 3.9250 美元。分析師的評級各不相同，其中一位為 “賣出”，兩位為 “持有”，兩位為 “買入”，一位為 “強烈買入”。機構投資者增加了持股，Vanguard Group 和 Geode Capital Management 的增持尤為顯著。該股票開盤價為 2.28 美元，市值為 11.8 億美元。最近的財報未能達到預期，報告每股虧損 0.05 美元</p>

<p>Shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) have been assigned a consensus recommendation of &#34;Moderate Buy&#34; from the six analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $3.9250.</p>
<div class="lb-trans"><p>Clover Health Investments, Corp.（納斯達克代碼：CLOV - 獲取免費報告）的股票獲得了六位分析師的共識推薦，評級為 “適度買入”，Marketbeat 報道稱。其中一位分析師給予該股票賣出評級，兩位分析師給予持有評級，兩位分析師給予買入評級，還有一位分析師給予強烈買入評級。在過去一年中，更新了對該股票覆蓋的經紀人中，12 個月的平均目標價為 3.9250 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 03/03 - 03/07</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 週迴顧 – 03/03 - 03/07</li>
</ul>
</div><p>Several equities analysts have commented on the company. Zacks Research raised Clover Health Investments from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, October 24th. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Clover Health Investments in a research note on Wednesday. Canaccord Genuity Group reduced their price target on shares of Clover Health Investments from $4.10 to $3.70 and set a &#34;buy&#34; rating on the stock in a research note on Thursday, November 6th. Wall Street Zen lowered shares of Clover Health Investments from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, November 15th. Finally, Leerink Partners set a $3.00 target price on shares of Clover Health Investments and gave the stock a &#34;market perform&#34; rating in a research note on Tuesday, October 21st.</p>
<div class="lb-trans"><p>幾位股票分析師對該公司進行了評論。Zacks Research 在 10 月 24 日（星期五）的研究報告中將 Clover Health Investments 的評級從 “持有” 上調至 “強烈買入”。Weiss Ratings 在週三的研究報告中重新發布了對 Clover Health Investments 股票的 “賣出（d-）” 評級。Canaccord Genuity Group 在 11 月 6 日（星期四）的研究報告中將 Clover Health Investments 的目標價從 4.10 美元下調至 3.70 美元，並對該股票給予 “買入” 評級。Wall Street Zen 在 11 月 15 日（星期六）的報告中將 Clover Health Investments 的評級從 “持有” 下調至 “賣出”。最後，Leerink Partners 在 10 月 21 日（星期二）的研究報告中對 Clover Health Investments 的股票設定了 3.00 美元的目標價，並給予該股票 “市場表現” 評級。</p>
</div><p><strong>Read Our Latest Report on CLOV</strong></p>
<div class="lb-trans"><p><strong>閲讀我們關於 CLOV 的最新報告</strong></p>
</div><h2>Institutional Investors Weigh In On Clover Health Investments</h2>
<div class="lb-trans"><h2>機構投資者對 Clover Health Investments 的看法</h2>
</div><ul>
<li>Missed the Hims &amp; Hers Rally? Clover Health Could Be Next</li>
</ul>
<div class="lb-trans"><ul>
<li>錯過了 Hims &amp; Hers 的上漲？Clover Health 可能是下一個</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of CLOV. Vanguard Group Inc. grew its position in shares of Clover Health Investments by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 20,580,117 shares of the company's stock worth $73,883,000 after buying an additional 994,904 shares in the last quarter. Geode Capital Management LLC grew its holdings in Clover Health Investments by 95.7% during the 2nd quarter. Geode Capital Management LLC now owns 9,843,349 shares of the company's stock worth $27,467,000 after acquiring an additional 4,812,368 shares in the last quarter. Millennium Management LLC increased its position in Clover Health Investments by 365.9% during the 1st quarter. Millennium Management LLC now owns 5,804,006 shares of the company's stock valued at $20,836,000 after purchasing an additional 4,558,305 shares during the period. Bank of America Corp DE increased its position in Clover Health Investments by 217.5% during the 2nd quarter. Bank of America Corp DE now owns 4,012,744 shares of the company's stock valued at $11,196,000 after purchasing an additional 2,748,783 shares during the period. Finally, Divisadero Street Capital Management LP bought a new stake in shares of Clover Health Investments in the 3rd quarter valued at about $8,470,000. 19.77% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些機構投資者和對沖基金最近買入和賣出了 CLOV 的股票。Vanguard Group Inc. 在第一季度將其在 Clover Health Investments 的持股增加了 5.1%。Vanguard Group Inc. 現在擁有 20580117 股該公司的股票，價值 73883000 美元，此前在上個季度又購買了 994904 股。Geode Capital Management LLC 在第二季度將其在 Clover Health Investments 的持股增加了 95.7%。Geode Capital Management LLC 現在擁有 9843349 股該公司的股票，價值 27467000 美元，此前在上個季度又收購了 4812368 股。Millennium Management LLC 在第一季度將其在 Clover Health Investments 的持股增加了 365.9%。Millennium Management LLC 現在擁有 5804006 股該公司的股票，價值 20836000 美元，此前在此期間又購買了 4558305 股。美國銀行（Bank of America Corp DE）在第二季度將其在 Clover Health Investments 的持股增加了 217.5%。美國銀行（Bank of America Corp DE）現在擁有 4012744 股該公司的股票，價值 11196000 美元，此前在此期間又購買了 2748783 股。最後，Divisadero Street Capital Management LP 在第三季度購買了價值約 8470000 美元的 Clover Health Investments 新股份。19.77% 的股票由機構投資者持有。</p>
</div><h2>Clover Health Investments Trading Up 5.6%</h2>
<div class="lb-trans"><h2>Clover Health Investments 股票上漲 5.6%</h2>
</div><p>Clover Health Investments stock opened at $2.28 on Friday. Clover Health Investments has a 12-month low of $2.12 and a 12-month high of $4.87. The firm has a 50-day moving average price of $2.92 and a 200-day moving average price of $2.94. The firm has a market capitalization of $1.18 billion, a PE ratio of -20.73 and a beta of 2.07.</p>
<div class="lb-trans"><p>Clover Health Investments 股票在週五開盤價為 2.28 美元。Clover Health Investments 的 12 個月最低價為 2.12 美元，最高價為 4.87 美元。該公司的 50 日移動平均價格為 2.92 美元，200 日移動平均價格為 2.94 美元。該公司的市值為 11.8 億美元，市盈率為-20.73，貝塔係數為 2.07。</p>
</div><p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.07). Clover Health Investments had a negative return on equity of 16.79% and a negative net margin of 3.29%.The firm had revenue of $496.65 million during the quarter, compared to analysts' expectations of $467.18 million. As a group, sell-side analysts predict that Clover Health Investments will post -0.12 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Clover Health Investments（納斯達克代碼：CLOV - 獲取免費報告）最近於 11 月 4 日（星期二）發佈了季度財報。該公司報告的每股收益為（0.05 美元），低於分析師的共識預期（0.02 美元）0.07 美元。Clover Health Investments 的股本回報率為-16.79%，淨利潤率為-3.29%。該公司在本季度的收入為 4.9665 億美元，而分析師的預期為 4.6718 億美元。作為一個整體，賣方分析師預測 Clover Health Investments 在當前財政年度的每股收益將為-0.12 美元。</p>
</div><h2>About Clover Health Investments</h2>
<div class="lb-trans"><h2>關於 Clover Health Investments</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（獲取免費報告）</p>
</div><p>Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.</p>
<div class="lb-trans"><p>Clover Health Investments, Corp. 在美國提供醫療保險優勢計劃。它通過兩個部門運營：保險和非保險。它還提供 Clover Assistant，這是一個基於雲的軟件平台，使醫生能夠更早地檢測、識別和管理慢性疾病；併為他們治療的患者提供數據驅動和個性化的見解。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精選故事</h2>
</div><ul>
<li>Five stocks we like better than Clover Health Investments</li>
<li>ETF Screener: Uses and Step-by-Step Guide</li>
<li>Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger</li>
<li>P/E Ratio Calculation: How to Assess Stocks</li>
<li>MarketBeat Week in Review – 11/17 - 11/21</li>
<li>What does consumer price index measure?</li>
<li>A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves</li>
</ul>
<div class="lb-trans"><ul>
<li>五隻我們更看好的股票，勝過 Clover Health Investments</li>
<li>ETF 篩選器：用途和逐步指南</li>
<li>Rocket Lab 剛經歷了第一次真正的崩潰——反彈可能更大</li>
<li>市盈率計算：如何評估股票</li>
<li>MarketBeat 週迴顧 – 11/17 - 11/21</li>
<li>消費者物價指數測量什麼？</li>
<li>一個宏偉的人工智能投資？Stanley Druckenmiller 最新的科技動態</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CLOV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍述科學技術和來自 MarketBeat 的金融數據生成，以便為讀者提供最快的報道和公正的覆蓋。請將任何問題或意見發送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Clover Health Investments Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1000 美元在 Clover Health Investments 嗎？</h2>
</div><p>Before you consider Clover Health Investments, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考慮 Clover Health Investments 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄向客户推薦的股票，以便在更廣泛的市場注意到之前立即購買……而 Clover Health Investments 並不在名單上。</p>
</div><p>While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Clover Health Investments 目前在分析師中獲得了適度買入評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

三葉草健康投資公司（NASDAQ:CLOV）被券商一致推薦為 “適度買入”